Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent
Seulgi Shin(Convergence Research Center for Diagnosis Treatment and Care System of Dementia), Yun Kyung Kim(Korea Institute of Science and Technology)
Cited by 3
Related Papers
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
|Experimental & Molecular Medicine|2018|43